DexCom, Inc. (BMV:DXCM)

Market Cap	470.23B -32.9%
Revenue (ttm)	82.83B +14.2%
Net Income	13.22B +5.9%
EPS	32.96 +7.8%
Shares Out	n/a
PE Ratio	35.57
Forward PE	28.56
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7
Average Volume	6,143
Open	1,230.00
Previous Close	n/a
Day's Range	1,230.00 - 1,230.00
52-Week Range	1,062.55 - 1,788.70
Beta	n/a
RSI	49.67
Earnings Date	Feb 12, 2026

About DexCom

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1999
• Employees: 10,300
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: DXCM

Financial Performance

In 2024, DexCom's revenue was $4.03 billion, an increase of 11.34% compared to the previous year's $3.62 billion. Earnings were $576.20 million, an increase of 6.41%.

Financial numbers in USD